Investors have given a vote of confidence to current management’s recent turnaround efforts. Boston Scientific’s stock price has more than doubled this year, after about four years in which it had been stuck in the single-digit range. …
A smaller company, Boston Scientific Corp (NYSE:BSX), with a market cap of $26B ... Some companies are doing truly great. Stock picking is mandatory in this stage, until the biotech index shows a confirmed breakout, at which point …
Johnson & Johnson has moved on from the deal. It received a $705 million breakup fee from Boston Scientific. Since 2004, Johnson & Johnson’s stock has soared 83 percent, and the company is now worth $288 billion. Boston
Boston Scientific Reports 1Q16 Earnings: What Was the Reaction? 1Q16 takeaways On April 27, 2016, Boston Scientific (BSX) released its 1Q16 earnings. After the announcement, Boston Scientific’s share price rose by ~11% …
Boston Scientific Corp. shares climbed after it won approval for ... Analysts also noted that revenue from spinal products was below expectations. The stock was off marginally in recent action to $58.22.
Boston Scientific shares have risen 37 percent since the beginning of the year, while the Standard & Poor's 500 index has increased 14 percent. The stock has increased 32 percent in the last 12 months. This story was generated by …
The founders said the sales were automatic trades triggered by the need to cover collateralized loans, and don’t reflect on the company.
Jan 29 (Reuters) - Boston Scientific Corp said on Tuesday that it expected to return to top-line growth this year, an outlook that cheered investors, who bid the medical device maker’s shares up as much as 8 percent to a 1 1/2-year …
Boston Scientific plans to argue that Guidant did not knowingly violate the agreement, according to court papers. It has also questioned whether J&J can prove it lost money. J&J's stock has soared since, while Boston Scientific's has …
Boston Scientific’s stock still hasn’t fully recovered from its bidding war with rival Johnson & Johnson over Guidant: The stock currently trades below $14 a share, compared with a $25-per-share range at the start of 2006. Tobin has spent …